Medicine guide
EVUSHELD
As listed in the register: EVUSHELD 150 mg + 150 mg, solution injectable
150 mg + 150 mg · solution injectable et solution injectable
- Prescription only
- Active substance
- Cilgavimab + Tixagévimab
- Made by
- ASTRAZENECA AB
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | ASTRAZENECA AB |
|---|---|
| Active substance | Cilgavimab + Tixagévimab |
| Strength | 150 mg + 150 mg |
| Form | solution injectable et solution injectable |
| Route | intramusculaire |
| Dispensing (as stated by the register) | prescription initiale hospitalière annuelle · liste I · renouvellement non restreint |
| Marketed | No — authorised but not currently marketed, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/22/1651 |
| Name in the register | EVUSHELD 150 mg + 150 mg, solution injectable |
| Packs | 1 flacon(s) en verre de 1,5 ml - 1 flacon(s) en verre de 1,5 ml |
| CIS | 69232595 |
| CIP13 | 3400930254264 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).